218 related articles for article (PubMed ID: 3235967)
41. Iodine-131 uptake in focal bronchiectasis mimicking metastatic thyroid cancer.
Song HC; Heo YJ; Kim SM; Bom HS
Clin Nucl Med; 2003 Apr; 28(4):351-2. PubMed ID: 12642729
[No Abstract] [Full Text] [Related]
42. [Lungs absorbed dose in radioiodine therapy of differentiated thyroid carcinoma with diffuse pulmonary metastases].
Liu B; Zeng Y; Wang J; Zhao Z; Mu D; Kuang A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):851-4. PubMed ID: 20842858
[TBL] [Abstract][Full Text] [Related]
43. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131.
Park HM; Perkins OW; Edmondson JW; Schnute RB; Manatunga A
Thyroid; 1994; 4(1):49-54. PubMed ID: 8054861
[TBL] [Abstract][Full Text] [Related]
44. Long-term survival and low effective cumulative radioiodine doses to achieve remission in patients with 131Iodine-avid lung metastasis from differentiated thyroid cancer.
Pitoia F; Bueno F; Cross G
Clin Nucl Med; 2014 Sep; 39(9):784-90. PubMed ID: 24999689
[TBL] [Abstract][Full Text] [Related]
45. Radioiodine uptake by metastatic nonthyroidal adenocarcinoma of the lung in a patient with papillary thyroid carcinoma.
Sohn MH; Kim MW; Lim ST; Lee NR; Song EK; Yim CY
Clin Nucl Med; 2005 Apr; 30(4):269-70. PubMed ID: 15764888
[TBL] [Abstract][Full Text] [Related]
46. Thallium-201 SPECT increases detectability of thyroid cancer metastases.
Charkes ND; Vitti RA; Brooks K
J Nucl Med; 1990 Feb; 31(2):147-53. PubMed ID: 2313353
[TBL] [Abstract][Full Text] [Related]
47. [131I-accumulating pulmonary and bone metastases of differentiated thyroid cancer with low serum thyroglobulin levels--an exception in tumor follow-up?].
Arning G; Ehrenheim C; Schober O; Hundeshagen H
Nuklearmedizin; 1987 Jun; 26(3):139-42. PubMed ID: 3628022
[TBL] [Abstract][Full Text] [Related]
48. [Treatment of distant metastases of thyroid cancer using 131I].
Drozdovskiĭ BIa; Proshin VV
Med Radiol (Mosk); 1986 Jul; 31(7):18-20. PubMed ID: 3736381
[No Abstract] [Full Text] [Related]
49. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays.
Schlumberger M; Arcangioli O; Piekarski JD; Tubiana M; Parmentier C
J Nucl Med; 1988 Nov; 29(11):1790-4. PubMed ID: 3183748
[TBL] [Abstract][Full Text] [Related]
50. [Metabolic therapy with radioiodine of differentiated thyroid tumor].
Bestagno M; Campagnari G
Minerva Med; 1986 Nov; 77(44):2113-6. PubMed ID: 3785727
[No Abstract] [Full Text] [Related]
51. Experience in the management of thyroid carcinoma by I-131. A report of 39 cases.
Bricout P; Kibler RS
J Can Assoc Radiol; 1973 Dec; 24(4):323-7. PubMed ID: 4773908
[No Abstract] [Full Text] [Related]
52. Misinterpretation of iodine uptake in papillary thyroid carcinoma and primary lung adenocarcinoma.
Langsteger W; Lind P; Költringer P; Beham A; Eber O
J Cancer Res Clin Oncol; 1990; 116(1):8-12. PubMed ID: 2312607
[TBL] [Abstract][Full Text] [Related]
53. [A comparison of 201Tl and 99mTc-MIBI in the follow-up of differentiated thyroid carcinomas].
Briele B; Hotze A; Kropp J; Bockisch A; Overbeck B; Grünwald F; Kaiser W; Biersack HJ
Nuklearmedizin; 1991 Aug; 30(4):115-24. PubMed ID: 1788076
[TBL] [Abstract][Full Text] [Related]
54. [Non-iodine-absorbing metastasis of differentiated thyroid cancer--therapeutic probe with 13-cis retinoic acid].
Kaniewski M; Czetwertyńska M; Godlewska P; Drac-Kaniewska J
Wiad Lek; 2001; 54 Suppl 1():297-300. PubMed ID: 12182038
[TBL] [Abstract][Full Text] [Related]
55. 131I treatment of thyroid papillary carcinoma in a patient with renal failure.
Morrish DW; Filipow LJ; McEwan AJ; Schmidt R; Murland KR; von Westarp C; Betcher KB
Cancer; 1990 Dec; 66(12):2509-13. PubMed ID: 2249192
[TBL] [Abstract][Full Text] [Related]
56. [Value of posttherapeutic scintigraphy for the demonstration of distant metastases of differentiated carcinomas of the thyroid gland].
Moser E; Hahn D; Wendt T; Büll U
Strahlentherapie; 1983 Apr; 159(4):217-23. PubMed ID: 6857735
[TBL] [Abstract][Full Text] [Related]
57. Pulmonary metastases from differentiated thyroid carcinoma demonstrable only by nuclear imaging.
Bonte FJ; McConnell RW
Radiology; 1973 Jun; 107(3):585-90. PubMed ID: 4702537
[No Abstract] [Full Text] [Related]
58. Radioiodine and radiotherapy in the management of thyroid cancers.
Simpson WJ
Otolaryngol Clin North Am; 1990 Jun; 23(3):509-21. PubMed ID: 1694984
[TBL] [Abstract][Full Text] [Related]
59. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.
Durante C; Haddy N; Baudin E; Leboulleux S; Hartl D; Travagli JP; Caillou B; Ricard M; Lumbroso JD; De Vathaire F; Schlumberger M
J Clin Endocrinol Metab; 2006 Aug; 91(8):2892-9. PubMed ID: 16684830
[TBL] [Abstract][Full Text] [Related]
60. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations.
Ramanna L; Waxman A; Braunstein G
J Nucl Med; 1991 Mar; 32(3):441-6. PubMed ID: 2005453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
